search
Back to results

Endovascular Repair of Abdominal Aortic Aneurysms

Primary Purpose

Aortic Aneurysm, Abdominal

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Endovascular Repair of Abdominal Aortic Aneurysms Using TALENT AAA Stent Graft System
Sponsored by
Stanford University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Aortic Aneurysm, Abdominal

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:1. Patient has one of the following:

  • Aneurysm >4 cm in diameter, or an aneurysm that has increased in size by 0.5 cm in the last 6-months
  • Aneurysm is 1.5 times larger than the diameter of the normal infrarenal aorta or symptomatic
  • Aneurysm is saccular
  • Penetrating ulcer 2. Patient's vascular dimensions must be in the range that can be safely treated with the stent graft available to the physician at the time of the procedure.

    3. Patient has endovascular access to the aneurysmal site with the Introducer Sheath or Delivery Catheter of the appropriate ize device chosen for treatment.

    4. Patient has anatomic characteristics suitable for endovascular repair. 5. Patient has an immediate life-threatening disease of the abdominal aorta in which there is a reasonable likelihood that death will occur within a matter of months or in which premature death is likely without early treatment.

    6. Patient is American Society of Anesthesiology (ASA) grade 1 through 4. 7. Patient is able and willing to comply with 3 month, 6 month, 1 year and every year thereafter post treatment follow-up requirements.

    8. Patient or patient's legal representative understands and has signed an Informed Consent.
 Exclusion Criteria:1. Patient is pregnant or nursing. 2. Patient is morbidly obese or has other clinical conditions that severely inhibit X-ray visualization of the aorta.

    3. Patient has connective disease. 4. Patient is hypercoagulable. 5. Patient has active systemic infection. 6. Patient is less than 18 years old. 7. Patient has less than a one-year life expectancy. 8. Patient is unwilling or unable to return for follow-up visits.

Sites / Locations

  • Stanford University School of Medicine

Outcomes

Primary Outcome Measures

Delivery success
Deployment success
Stent graft migration
Aneurysm exclusion
Stent graft patency
Device integrity
Major morbidity and mortality
Vessel perforation
Stent graft occlusion
Collateral vessel occlusion
Aneurysm rupture

Secondary Outcome Measures

Technical success
Patency

Full Information

First Posted
December 4, 2007
Last Updated
October 5, 2020
Sponsor
Stanford University
search

1. Study Identification

Unique Protocol Identification Number
NCT00803075
Brief Title
Endovascular Repair of Abdominal Aortic Aneurysms
Official Title
TALENT Endoluminal Stent Graft System for the Treatment of Abdominal Aortic Aneurysms
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
February 2002 (Actual)
Primary Completion Date
December 2005 (Actual)
Study Completion Date
December 2005 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Stanford University

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to determine if it is safe and effective to use the TALENT AAA Stent Graft System as a treatment for AAAs in patients who are also candidates for conventional surgical aneurysm repair.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Aneurysm, Abdominal

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
142 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Endovascular Repair of Abdominal Aortic Aneurysms Using TALENT AAA Stent Graft System
Primary Outcome Measure Information:
Title
Delivery success
Title
Deployment success
Title
Stent graft migration
Title
Aneurysm exclusion
Title
Stent graft patency
Title
Device integrity
Title
Major morbidity and mortality
Title
Vessel perforation
Title
Stent graft occlusion
Title
Collateral vessel occlusion
Title
Aneurysm rupture
Secondary Outcome Measure Information:
Title
Technical success
Title
Patency

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:1. Patient has one of the following: Aneurysm >4 cm in diameter, or an aneurysm that has increased in size by 0.5 cm in the last 6-months Aneurysm is 1.5 times larger than the diameter of the normal infrarenal aorta or symptomatic Aneurysm is saccular Penetrating ulcer 2. Patient's vascular dimensions must be in the range that can be safely treated with the stent graft available to the physician at the time of the procedure. 3. Patient has endovascular access to the aneurysmal site with the Introducer Sheath or Delivery Catheter of the appropriate ize device chosen for treatment. 4. Patient has anatomic characteristics suitable for endovascular repair. 5. Patient has an immediate life-threatening disease of the abdominal aorta in which there is a reasonable likelihood that death will occur within a matter of months or in which premature death is likely without early treatment. 6. Patient is American Society of Anesthesiology (ASA) grade 1 through 4. 7. Patient is able and willing to comply with 3 month, 6 month, 1 year and every year thereafter post treatment follow-up requirements. 8. Patient or patient's legal representative understands and has signed an Informed Consent.
 Exclusion Criteria:1. Patient is pregnant or nursing. 2. Patient is morbidly obese or has other clinical conditions that severely inhibit X-ray visualization of the aorta. 3. Patient has connective disease. 4. Patient is hypercoagulable. 5. Patient has active systemic infection. 6. Patient is less than 18 years old. 7. Patient has less than a one-year life expectancy. 8. Patient is unwilling or unable to return for follow-up visits.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher K Zarins MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jason T. Lee
Organizational Affiliation
Stanford University
Official's Role
Sub-Investigator
Facility Information:
Facility Name
Stanford University School of Medicine
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Endovascular Repair of Abdominal Aortic Aneurysms

We'll reach out to this number within 24 hrs